Agam Vora

794 total citations
43 papers, 498 citations indexed

About

Agam Vora is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Agam Vora has authored 43 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Infectious Diseases and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Agam Vora's work include Respiratory and Cough-Related Research (9 papers), Asthma and respiratory diseases (8 papers) and Pediatric health and respiratory diseases (6 papers). Agam Vora is often cited by papers focused on Respiratory and Cough-Related Research (9 papers), Asthma and respiratory diseases (8 papers) and Pediatric health and respiratory diseases (6 papers). Agam Vora collaborates with scholars based in India, United States and Belgium. Agam Vora's co-authors include Mangesh Tiwaskar, Shashank Joshi, Hanmant Barkate, Saiprasad Patil, Deepak Talwar, Abdul Samad Ansari, Zarir Udwadia, Christoph Lange, Ashish Agrawal and Sanjay R. Patel and has published in prestigious journals such as British Journal of Haematology, International Journal of Infectious Diseases and Frontiers in Public Health.

In The Last Decade

Agam Vora

37 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agam Vora India 8 277 92 85 72 47 43 498
Mangesh Tiwaskar India 11 254 0.9× 90 1.0× 108 1.3× 77 1.1× 50 1.1× 96 691
Saiprasad Patil India 8 366 1.3× 87 0.9× 101 1.2× 118 1.6× 57 1.2× 38 658
Isabelle Duflot France 6 322 1.2× 51 0.6× 58 0.7× 85 1.2× 80 1.7× 7 488
Abdul Samad Ansari India 5 232 0.8× 65 0.7× 62 0.7× 70 1.0× 42 0.9× 10 391
Jakob J Malin Germany 10 288 1.0× 68 0.7× 119 1.4× 67 0.9× 42 0.9× 25 479
Maochen Li China 9 338 1.2× 69 0.8× 156 1.8× 39 0.5× 38 0.8× 21 597
Isra Ahmad Farouk Malaysia 4 239 0.9× 67 0.7× 93 1.1× 76 1.1× 43 0.9× 4 520
Mohammed Kanan Alshammari Saudi Arabia 15 172 0.6× 114 1.2× 195 2.3× 30 0.4× 52 1.1× 56 643
Isabelle Suárez Germany 10 329 1.2× 175 1.9× 111 1.3× 35 0.5× 31 0.7× 36 659
Laura J. Szewczyk United States 3 420 1.5× 122 1.3× 73 0.9× 70 1.0× 58 1.2× 3 506

Countries citing papers authored by Agam Vora

Since Specialization
Citations

This map shows the geographic impact of Agam Vora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agam Vora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agam Vora more than expected).

Fields of papers citing papers by Agam Vora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agam Vora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agam Vora. The network helps show where Agam Vora may publish in the future.

Co-authorship network of co-authors of Agam Vora

This figure shows the co-authorship network connecting the top 25 collaborators of Agam Vora. A scholar is included among the top collaborators of Agam Vora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agam Vora. Agam Vora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vora, Agam, et al.. (2025). Impact of COVID-19 Pandemic on Incidence and Prevalence of Cough and its Types: A Real-world Study. Journal of the Association of Physicians of India. 73(6). 7–13.
2.
Vora, Agam, et al.. (2025). Levodropropizine: Comprehensive Review of the Peripheral Antitussive. Journal of the Association of Physicians of India. 73(7). e35–e44.
3.
Vora, Agam, et al.. (2025). The Role of Adult Pneumococcal Vaccination in Combating Antimicrobial Resistance: An Indian Perspective. Journal of the Association of Physicians of India. 73(S5). 35–38.
4.
Vora, Agam, Jyotirmoy Pal, Surinder K. Jindal, et al.. (2024). Association of Physicians of India: National Expert Opinion and Clinical Practice Recommendations for Primary Care Cough Management in India. Journal of the Association of Physicians of India. 72(10). 77–82. 1 indexed citations
5.
Tiwaskar, Mangesh, et al.. (2024). Defeating the Silent Enemy: Antimicrobial Resistance Looming as the Next Global Pandemic. Journal of the Association of Physicians of India. 72(3). 66–72.
6.
Arora, V.K., S K Katiyar, Deepak Talwar, et al.. (2023). Genomic revolution: Transforming tuberculosis diagnosis and treatment with the use of Whole Genome Sequencing - A consensus statement. Indian Journal of Tuberculosis. 70(4). 383–389. 2 indexed citations
7.
Ramasubramanian, V, et al.. (2023). Proceedings of the expert consensus group meeting on herpes zoster disease burden and prevention in India: An opinion paper. Human Vaccines & Immunotherapeutics. 19(2). 2220608–2220608. 1 indexed citations
8.
Tiwaskar, Mangesh & Agam Vora. (2023). Unveiling the Uncertainties: Exploring the Utility of Herpes Zoster Vaccines. Journal of the Association of Physicians of India. 71(11). 11–12. 1 indexed citations
9.
Joshi, Shashank, et al.. (2022). Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India. PubMed. Volume 13. 33–41. 7 indexed citations
10.
Vora, Agam, et al.. (2022). Monkeypox: What do we know so far? A short narrative review of literature. Journal of the Association of Physicians of India. 70(7). 87–90. 15 indexed citations
12.
Vora, Agam, et al.. (2021). Herpes zoster in outpatient departments of healthcare centers in India: a review of literature. Human Vaccines & Immunotherapeutics. 17(11). 4155–4162. 12 indexed citations
13.
Bhagat, Sarbottam, et al.. (2021). Clinical usefulness of favipiravir in moderate COVID-19 patients: Indian real-world experience. Indian Journal of Critical Care Medicine. 25. 1 indexed citations
14.
Vora, Agam, et al.. (2021). Vaccination in Older Adults: An Underutilized Opportunity to Promote Healthy Aging in India. Drugs & Aging. 38(6). 469–479. 5 indexed citations
15.
Vora, Agam, et al.. (2021). Awareness, Attitude, and Current Practices Toward Influenza Vaccination Among Physicians in India: A Multicenter, Cross-Sectional Study. Frontiers in Public Health. 9. 642636–642636. 9 indexed citations
16.
Udwadia, Zarir, et al.. (2020). COVID-19 -Tuberculosis interactions: When dark forces collide. Indian Journal of Tuberculosis. 67(4). S155–S162. 41 indexed citations
17.
Joshi, Shashank, Abdul Samad Ansari, Agam Vora, et al.. (2020). Role of favipiravir in the treatment of COVID-19. International Journal of Infectious Diseases. 102. 501–508. 327 indexed citations
19.
Vora, Agam & Krupa Krishnaprasad. (2017). Guiding Principles for the use of Fluroquinolones in Out-patient Community Settings of India: Panel Consensus.. PubMed. 65(8). 51–52. 1 indexed citations
20.
Vora, Agam & Amit Bhargava. (2016). A Cross-sectional Cohort Analyses Assessing Response to Levosalbutamol Bronchodilatory Cough Formulations in Outpatient Community Settings of India: 'BUS' analyses.. PubMed. 64(9). 45–48. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026